| Note |
A head start for the clinically depressed patient. All tricyclic antidepressants take from one to four weeks before optimal antidepressant effect is seen. Sinequan (doxepin HCl) - the newest tricyclic antidepressant - is no exception. But, in that waiting period, Sinequan alone offers the clinically depressed patient both: prompt sedative activity to begin relieving the sleep disturbances often characteristic of depression, and marked antianxiety activity to help relieve the apprehension, tension, worry and fear that usually accompany depression. Further, the incidence of cardiovascular side effects with Sinequan is relatively low. Tachycardia and hypotension are infrequent (Drowsiness is the most common side effect). And Sinequan, unlike other tricyclic antidepressants, does not generally affect the activity of guanethidine and similarly acting compounds at usual clinical doses. Prompt sedative activity. Marked antianxiety activity. Low incidence of cardiovascular side effects. It's a head start for the clinically depressed patient. The newest tricyclic antidepressant- with differences you can see. Sinequan. Doxepin HCl. 25-mg and 50-mg. capsules. Sinequan Doxepin HCl. 25-mg. and 50-mg. capsules. The newest tricyclic antidepressant- with differences you can see. |
